Skip to content

Effect of anahealbormelain on clinical parameters of periodontal in non-surgical paients with chronic periodontitis

Effect of anahealbormelain on clinical parameters of periodontal in non-surgical paients with chronic periodontitis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017051114440N3
Enrollment
40
Registered
2017-07-08
Start date
2015-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with chronic periodontitis. Chronic periodontitis

Interventions

Intervention 1: Intervention group: Scaling , root planning, Anaheal Bromelain prescription four times a day for eight weeks. Intervention 2: Control group: Scaling ,root planning, placebo prescriptio
Treatment - Drugs
Placebo
Intervention group: Scaling , root planning, Anaheal Bromelain prescription four times a day for eight weeks
Control group: Scaling ,root planning, placebo prescription four times a day

Sponsors

Department of Periodontics of Dental Faculty of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients who suffer from moderate chronic periodontitis with clinical attachment loss (CAL) of 3 to 4 millimeters who were systemically healthy. Exclusion criteria : Sensitivity to the medication (patients with sensitivity to pineapple, celery, carrot and fennel may also have sensitivity to Bromelain),History of cardiac diseases, Pregnant women, Gastrointestinal diseases such as peptic ulcer, Renal or Hepatic Diseases, coagulated anomalies such as hemophilia, Systemic lupus erythematous, Any history of periodontal treatment (scaling, root planning or surgery) at the past six months, Alcohol, cigarette or drug consumption, Concurrent Anti-coagulant or thrombolytic therapy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
CAL (clinical attachment level). Timepoint: before the intervention, four weeks after initiating the intervention and eight weeks after initiating the intervention. Method of measurement: measurement of the distance between the stent margin to the sulcus base by means of a periodontal probe.

Secondary

MeasureTime frame
Plaque. Timepoint: Before the intervention, four weeks after initiating the intervention and eight weeks after initiating the intervention. Method of measurement: by disclosing agent with visual scale.;Bleeding on probing(BOP). Timepoint: before the intervention, four weeks after initiating the intervention and eight weeks after initiating the intervention. Method of measurement: bleeding in 15 seconds after gentle probing by periodontal probe.;Probing depth(PD). Timepoint: Before the intervention, four weeks after initiating the intervention and eight weeks after initiating the intervention. Method of measurement: The distance between the mucosal margin and the sulcus base by periodontal probe in millimeters.;Gingival index(GI). Timepoint: before the intervention, four weeks after initiating the intervention and eight weeks after initiating the intervention. Method of measurement: observation of index score.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Zarandi

Department of Periodontics of Dental Faculty of Tabriz University of Medical Sciences

zarandia@tbzmed.ac ; dr.alizarandi@gmail.com+98 41 3334 6977

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026